NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome

NeuroThera Labs Inc. (TSXV: NTLX) (the "Company" or "NeuroThera"), a clinical-stage biotech company and a majority-owned ...
Benzinga.com

SciSparc To Conduct Clinical Trial For Dronabinol-Based Drug To Treat Tourette Syndrome In Germany

SciSparc Ltd. SPRC has been granted an approval from the Federal Institute for Drugs and Medical Devices in Germany (“BfArM”) for its phase IIb clinical trial to use SCI-110 for treating adults with ...
Rolling Stone

Crowd Takes Over ‘Someone You Loved’ After Lewis Capaldi Experiences Tourette’s Syndrome Tics During Live Show

Fans in Frankfurt, Germany, stepped in for Lewis Capaldi on Tuesday night when the singer experienced a flare-up of tics from his Tourette’s syndrome. During the last song of the night and his biggest ...
ksn.com

SciSparc Receives Approval to Conduct Phase IIb Clinical Trial for SCI-110 to Treat Tourette Syndrome in Germany

The Federal Institute for Drugs and Medical Devices in Germany granted the Company approval to use SCI-110 in a clinical trial at the Hannover Medical School TEL AVIV, Israel, June 30, 2023 (GLOBE ...

SciSparc: NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome

SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that its subsidiary NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on ...